Forbes March 21, 2024
Digital diabetes management tools “fail to deliver meaningful benefits to patients” while at the same time increasing the cost of healthcare to consumers, health insurers and taxpayers, a new report finds.
Digital diabetes management solutions, which connect a “noncontinous glucose monitor” that can transmit data to a phone, computer or electronic record for tracking purposes, “consistently demonstrate that they help patients achieve small reductions in HbA1c beyond what they would achieve with usual care, but the evidence rarely reported improvement that exceeded commonly-used thresholds for meaningful clinical benefit,” said the Peterson Health Technology Institute.
“These solutions are used by millions of Americans and have been funded by $58 billion of investment and mergers and acquisitions, yet the evidence shows...
Today's Sponsors
Today's Sponsor